{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:20:28Z","timestamp":1791980428042,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.biopha.2018.06.047","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T09:08:05Z","timestamp":1529399285000},"page":"1042-1049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-4432","authenticated-orcid":false,"given":"Lorenzo","family":"Di Cesare Mannelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Irace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"De Feo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mascolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.06.047_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.2014-0044","article-title":"Platinum-induced neurotoxicity and preventive strategies: past, present, and future","volume":"20","author":"Avan","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.biopha.2018.06.047_bib0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2014.10.014","article-title":"Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?","volume":"596","author":"Carozzi","year":"2015","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.biopha.2018.06.047_bib0015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/jnnp-2013-305334","article-title":"Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients","volume":"85","author":"Velasco","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.biopha.2018.06.047_bib0020","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00280-012-2006-8","article-title":"Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer","volume":"70","author":"Lucchetta","year":"2012","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0025","first-page":"249","article-title":"Management of oxaliplatin-induced peripheral neuropathy","volume":"1","author":"Saif","year":"2005","journal-title":"Ther Clin Risk Manag."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.06.047_bib0030","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.3816\/CCC.2005.s.006","article-title":"Clinical management of oxaliplatin-associated neurotoxicity","volume":"5","author":"Grothey","year":"2005","journal-title":"Clin Colorectal Cancer."},{"key":"10.1016\/j.biopha.2018.06.047_bib0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/09637486.2011.628012","article-title":"Nutraceuticals and botanicals: overview and perspectives","volume":"63","author":"Nicoletti","year":"2012","journal-title":"Int J Food Sci Nutr."},{"key":"10.1016\/j.biopha.2018.06.047_bib0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejps.2016.09.003","article-title":"Nutraceuticals: A paradigm of proactive medicine","volume":"96","author":"Santini","year":"2017","journal-title":"Eur J Pharm Sci."},{"key":"10.1016\/j.biopha.2018.06.047_bib0045","series-title":"Flora of China","author":"Li","year":"1994"},{"key":"10.1016\/j.biopha.2018.06.047_bib0050","series-title":"Pharmacopoeia of the People\u2019s Republic of China","author":"Pharmacopoeia Committee of the People\u2019s Republic of China","year":"2005"},{"key":"10.1016\/j.biopha.2018.06.047_bib0055","first-page":"1205","article-title":"Biological activity of bicyclic and tricyclic diterpenoids from Salvia species of immediate pharmacological and pharmaceutical interest","volume":"6","author":"Bonito","year":"2011","journal-title":"Nat Prod Commun."},{"key":"10.1016\/j.biopha.2018.06.047_bib0060","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jep.2014.07.010","article-title":"a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway","volume":"155","author":"Maione","year":"2014","journal-title":"J Ethnopharmacol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.fitote.2014.11.024","article-title":"Molecular mechanism of tanshinone IIA and cryptotanshinone in platelet anti-aggregating effects: an integrated study of pharmacology and computational analysis","volume":"100","author":"Maione","year":"2015","journal-title":"Fitoterapia."},{"key":"10.1016\/j.biopha.2018.06.047_bib0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-0036-1580086","article-title":"Danshen and the Cardiovascular System: New Advances for an Old Remedy","volume":"42","author":"Maione","year":"2016","journal-title":"Semin Thromb Hemost."},{"key":"10.1016\/j.biopha.2018.06.047_bib0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/13880209.2015.1027408","article-title":"Salvia miltiorrhiza: A source for anti-Alzheimer\u2019s disease drugs","volume":"54","author":"Zhang","year":"2016","journal-title":"Pharm Biol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0080","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2017.11.018","article-title":"Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer\u2019s disease","volume":"129","author":"Maione","year":"2018","journal-title":"Pharmacol Res."},{"key":"10.1016\/j.biopha.2018.06.047_bib0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cei.12993","article-title":"Tanshinone IIA ameliorates chronic arthritis in mice by modulating neutrophil activities","volume":"190","author":"Zhang","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.intimp.2017.06.017","article-title":"Cryptotanshinone protects against IL-1\u03b2-induced inflammation in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice","volume":"50","author":"Feng","year":"2017","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0095","series-title":"Anticancer agents based on natural product models","author":"Cassady","year":"1980"},{"key":"10.1016\/j.biopha.2018.06.047_bib0100","series-title":"Human Medicinal Agents from Plants","first-page":"80","article-title":"Role of plants in the National Cancer Institute Drug Discovery and Development Program","author":"Cragg","year":"1993"},{"key":"10.1016\/j.biopha.2018.06.047_bib0105","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/med.21304","article-title":"The anticancer properties of Salvia miltiorrhiza Bunge (Danshen): a systematic review","volume":"34","author":"Chen","year":"2014","journal-title":"Med Res Rev."},{"key":"10.1016\/j.biopha.2018.06.047_bib0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jep.2017.08.011","article-title":"Danshen improves survival of patients with colon cancer and dihydroisotanshinone I inhibit the proliferation of colon cancer cells via apoptosis and skp2 signaling pathway","volume":"209","author":"Lin","year":"2017","journal-title":"J Ethnopharmacol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0115","first-page":"559","article-title":"Effect of Tanshinone IIA in Preventing and Treating Oxaliplatin Induced Peripheral Neuropathy","volume":"36","author":"Xu","year":"2016","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.biopha.2018.06.047_bib0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jep.2015.01.042","article-title":"Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"164","author":"Wang","year":"2015","journal-title":"J Ethnopharmacol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12017-016-8399-5","article-title":"Potent Protection Against MPP-Induced Neurotoxicity via Activating Transcription Factor MEF2D by a Novel Derivative of Naturally Occurring Danshensu\/Tetramethylpyrazine","volume":"18","author":"Hu","year":"2016","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.biopha.2018.06.047_bib0130","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4517486","article-title":"Tanshinone IIA Inhibits Glutamate-Induced Oxidative Toxicity through Prevention of Mitochondrial Dysfunction and Suppression of MAPK Activation in SH-SY5Y Human Neuroblastoma Cells","author":"Li","year":"2017","journal-title":"Oxid Med Cell Longev."},{"issue":"6","key":"10.1016\/j.biopha.2018.06.047_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038381","article-title":"Tanshinone IIA attenuates the inflammatory response and apoptosis after traumatic injury of the spinal cord in adult rats","volume":"7","author":"Yin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.06.047_bib0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lfs.2014.07.020","article-title":"Tanshinone IIA dampens the cell proliferation induced by ischemic insult in rat astrocytes via blocking the activation of HIF-1\u03b1\/SDF-1 signaling","volume":"112","author":"Huang","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.06.047_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2014.11.004","article-title":"Tanshinone IIA attenuates neuropathic pain via inhibiting glial activation and immune response","volume":"128","author":"Cao","year":"2015","journal-title":"Pharmacol Biochem Behav."},{"key":"10.1016\/j.biopha.2018.06.047_bib0150","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0155","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/S0959-8049(01)00300-8","article-title":"Effects of different schedules of oxaliplatin on the peripheral nervous system of the rat","volume":"37","author":"Cavaletti","year":"2001","journal-title":"Eur. J. Cancer."},{"key":"10.1016\/j.biopha.2018.06.047_bib0160","doi-asserted-by":"crossref","first-page":"42021","DOI":"10.1038\/srep42021","article-title":"Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?","volume":"7","author":"Di Cesare Mannelli","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.biopha.2018.06.047_bib0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0028-3908(85)90076-0","article-title":"A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen","volume":"24","author":"Vaught","year":"1985","journal-title":"Neuropharmacology."},{"issue":"1","key":"10.1016\/j.biopha.2018.06.047_bib0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jcp.1041490105","article-title":"Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro","volume":"149","author":"Jumarie","year":"1991","journal-title":"J Cell Physiol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0175","doi-asserted-by":"crossref","first-page":"45236","DOI":"10.1038\/srep45236","article-title":"Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action","volume":"7","author":"Irace","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.biopha.2018.06.047_bib0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"Platinum neurotoxicity pharmacogenetics","volume":"8","author":"McWhiney","year":"2009","journal-title":"Mol Cancer Ther."},{"key":"10.1016\/j.biopha.2018.06.047_bib0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/sonc.2002.35525","article-title":"Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures","volume":"29","author":"Gamelin","year":"2002","journal-title":"Semin Oncol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pain.2009.03.024","article-title":"Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study","volume":"144","author":"Attal","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2018.06.047_bib0195","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/bph.13636","article-title":"Nutraceuticals in hypercholesterolaemia: an overview","volume":"174","author":"Santini","year":"2017","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.biopha.2018.06.047_bib0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2017.04.029","article-title":"Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels","volume":"121","author":"Di Cesare Mannelli","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2018.06.047_bib0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/CCO.0000000000000376","article-title":"Integrative medicine in cancer survivors","volume":"29","author":"Viscuse","year":"2017","journal-title":"Curr Opin Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2018.06.047_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128080","article-title":"Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity","volume":"10","author":"Di Cesare Mannelli","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biopha.2018.06.047_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102758","article-title":"Oxaliplatin neurotoxicity involves peroxisome alterations. PPAR\u03b3 agonism as preventive pharmacological approach","volume":"9","author":"Zanardelli","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2018.06.047_bib0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1213\/ANE.0000000000001998","article-title":"Interventions for Neuropathic Pain: An Overview of Systematic Reviews","volume":"125","author":"Dosenovic","year":"2017","journal-title":"Anesth Analg."},{"issue":"10","key":"10.1016\/j.biopha.2018.06.047_bib0225","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1039\/C4MD00186A","article-title":"Identification of tanshinone IIA as a natural monoacylglycerol lipase inhibitor by combined in silico and in vitro approach","volume":"5","author":"Yang","year":"2014","journal-title":"Med Chem Comm."},{"key":"10.1016\/j.biopha.2018.06.047_bib0230","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.phymed.2015.05.006","article-title":"Widespread pain reliever profile of a flower extract of Tanacetum parthenium","volume":"22","author":"Di Cesare Mannelli","year":"2015","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.biopha.2018.06.047_bib0235","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1021\/acs.jmedchem.5b01812","article-title":"Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain","volume":"59","author":"Brindisi","year":"2016","journal-title":"J Med Chem."},{"key":"10.1016\/j.biopha.2018.06.047_bib0240","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2014.05.005","article-title":"Antinociceptive effects of systemic tanshinone IIA on visceral and somatic persistent nociception and pain hypersensitivity in rats","volume":"124","author":"Cao","year":"2014","journal-title":"Pharmacol Biochem Behav."},{"key":"10.1016\/j.biopha.2018.06.047_bib0245","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/CAD.0000000000000127","article-title":"Antitumor effect of traditional Chinese herbal medicines against lung cancer","volume":"25","author":"Chen","year":"2014","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.biopha.2018.06.047_bib0250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.fitote.2014.11.008","article-title":"Multiple pro-apoptotic targets of abietane diterpenoids from Salvia species","volume":"100","author":"Akaberi","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2018.06.047_bib0255","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1038\/sj.onc.1205879","article-title":"Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells","volume":"21","author":"Hopkins-Donaldson","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2018.06.047_bib0260","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jss.2004.05.017","article-title":"Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells","volume":"122","author":"Wu","year":"2004","journal-title":"J Surg Res."},{"key":"10.1016\/j.biopha.2018.06.047_bib0265","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/ijc.11312","article-title":"Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin","volume":"106","author":"Pecere","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.biopha.2018.06.047_bib0270","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ijdevneu.2011.06.002","article-title":"Dietary phytochemicals induce p53- and caspase-independent cell death in human neuroblastoma cells","volume":"29","author":"Sukumari-Ramesh","year":"2011","journal-title":"Int J Dev Neurosci."},{"key":"10.1016\/j.biopha.2018.06.047_bib0275","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jchromb.2013.06.011","article-title":"A rapid UFLC-MS\/MS method for simultaneous determination of formononetin, cryptotanshinone, tanshinone IIA and emodin in rat plasma and its application to a pharmacokinetic study of Bu Shen Huo Xue formula","volume":"932","author":"Xu","year":"2013","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"10.1016\/j.biopha.2018.06.047_bib0280","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s11064-015-1751-6","article-title":"Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson\u2019s Disease Through Upregulating Nrf2","volume":"41","author":"Jing","year":"2016","journal-title":"Neurochem Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218323606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218323606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:41:40Z","timestamp":1731429700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218323606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":56,"alternative-id":["S0753332218323606"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.047","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}